2013
JAK2 or CALR mutation status defines subtypes of essential thrombocythemia with substantially different clinical course and outcomes.
Rumi E,
Pietra D,
Ferretti V,
Klampfl T,
Harutyunyan AS,
Milosevic JD,
Them NC,
Berg T,
Elena C,
Casetti IC,
Milanesi C,
Sant'antonio E,
Bellini M,
Fugazza E,
Renna MC,
Boveri E,
Astori C,
Pascutto C,
Kralovics R,
Cazzola M.
Blood. 2013 Dec 23. [Epub ahead of print]
2013
Efficacy of ruxolitinib in chronic eosinophilic leukemia associated with a PCM1-JAK2 fusion gene.
Rumi E,
Milosevic JD,
Casetti I,
Dambruoso I,
Pietra D,
Boveri E,
Boni M,
Bernasconi P,
Passamonti F,
Kralovics R,
Cazzola M.
J Clin Oncol. 2013 Jun 10; 31(17):e269-71.
2013
Overexpression of primary microRNA 221/222 in acute myeloid leukemia.
Rommer A,
Steinleitner K,
Hackl H,
Schneckenleithner C,
Engelmann M,
Scheideler M,
Vlatkovic I,
Kralovics R,
Cerny-Reiterer,
Valent P,
Sill H,
Wieser R.
BMC Cancer. 2013; 13: 364.
2013
A Target-Disease Network Model of Second-Generation BCR-ABL Inhibitor Action in Ph+ ALL.
Rix U,
Colinge J,
Blatt K,
Gridling M,
Remsing Rix LL,
Parapatics K,
Cerny-Reiterer S,
Burkard TR,
Jäger U,
Melo J,
Bennett KL,
Valent P,
Superti-Furga G.
PLoS One. 2013; 8(10): e77155.
2013
Protein interaction networks in innate immunity.
Rebsamen M,
Kandasamy RK,
Superti-Furga G.
Trends Immunol. 2013 Jul 1. S1471-4906(13)00079-3;
2013
IGHV1-69-Encoded Antibodies Expressed in Chronic Lymphocytic Leukemia React with Malondialdehyde–Acetaldehyde Adduct, an Immunodominant Oxidation-Specific Epitope.
Que X,
Widhopf II GF,
Amir S,
Hartvigsen K,
Hansen LF,
Woelkers D,
Tsimikas S,
Binder CJ,
Kipps TJ,
Witztum JL.
PLoS One. 2013; 8(6): e65203.
2013
Cancer. Potential of the synthetic lethality principle.
Nijman SM,
Friend SH.
Potential of the synthetic lethality principle. Science. 2013 Nov 15;342(6160):809-11. doi: 10.1126/science.1244669.
2013
Development and application of a nonradioactive binding assay of oxidized low-density lipoprotein to macrophage scavenger receptors.
Montano EN,
Boullier A,
Almazan F,
Binder CJ,
Witztum JL,
Hartvigsen K.
J Lipid Res. 2013 Nov;54(11):3206-3214.
2013
Recommendations for the design and analysis of epigenome-wide association studies.
Michels KB,
Binder AM,
Dedeurwaerder S,
Epstein CB,
Greally JM,
Gut I,
Houseman EA,
Izzi B,
Kelsey KT,
Meissner A,
Milosavljevic A,
Siegmund KD,
Bock C,
Irizarry RA.
Nat Methods. 2013 Oct;10(10):949-55. doi: 10.1038/nmeth.2632.
2013
The CRAPome: a Contaminant Repository for Affinity Purification Mass Spectrometry Data.
Mellacheruvu D,
Wright Z,
Couzens AL,
Lambert J-P,
St-Denis N,
Li T,
Mitev YV,
Hauri S,
Sardiu ME,
Low TY,
Halim VA,
Bagshaw RD,
Hubner NC,
al-Hakim A,
Bouchard A,
Faubert D,
Fermin D,
Dunham WH,
Goudreault M,
Lin Z-Y,
Gonzalez Badillo B,
Pawson T,
Durocher D,
Coulombe B,
Aebersold R,
Superti-Furga S,
Colinge J,
Heck AJR,
Choi H,
Gstaiger M,
Mohammed S,
Cristea IM,
Bennett KL,
Washburn MP,
Raught B,
Ewing RM,
Gingras A-C,
Nesvizhskii A.
Nature Methods May; 24(Suppl): S50–S51.
